Literature DB >> 24318967

Activated 5'flanking region of NANOGP8 in a self-renewal environment is associated with increased sphere formation and tumor growth of prostate cancer cells.

Kai Zhang1, Marcie Fowler, Jonathan Glass, Hong Yin.   

Abstract

INTRODUCTION: NANOGP8 is a retrogene which encodes a full-length protein similar to the NANOG1 gene. The expression of NANOGP8 has been documented in several cancers and is related to cell proliferation and tumor development. However, the regulation of NANOGP8 expression has not been investigated. Therefore, the role of NANOGP8 in cell proliferation has not been completely understood.
METHODS: We evaluate the expression of NANOG1 and NANOGP8 in prostate cancer cell lines and primary cultures of prostate tissues. We investigate clonogenicity, sphere formation, and xenograft tumor growth of prostate cancer cells with an activated 5'flanking region of NANOGP8. We examine the role of NANOGP8 in cell cycle progression.
RESULTS: In the prostate cells the NANOG RNA was transcribed from NANOGP8 and not from NANOG1. Cells with the activated 5'flanking region of NANOGP8 exhibited enhanced clonogenicity, sphere formation, and xenograft tumor growth. The sphere culture and tumor initiation mouse mode promoted the activation of the 5'flanking region of NANOGP8. Forced expression of NANOGP8 increased the entry into the cell cycle. DISCUSSION: In prostate cells NANOGP8 is a predominant molecule of NANOG. The activation of 5'flanking sequence of NANOGP8 could play a role in the regulation of the stem-like properties of cancer stem cells and prostate tumor initiation and development. The microenvironment favoring cancer stem cells could promote the activation of the 5'flanking region of NANOGP8.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  5′flanking region; NANOGP8; stem cells; tumor growth

Mesh:

Substances:

Year:  2013        PMID: 24318967     DOI: 10.1002/pros.22759

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  7 in total

Review 1.  Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions.

Authors:  Collene R Jeter; Tao Yang; Junchen Wang; Hsueh-Ping Chao; Dean G Tang
Journal:  Stem Cells       Date:  2015-05-13       Impact factor: 6.277

Review 2.  Regulation of NANOG in cancer cells.

Authors:  Shuai Gong; Qiuhui Li; Collene R Jeter; Qingxia Fan; Dean G Tang; Bigang Liu
Journal:  Mol Carcinog       Date:  2015-05-27       Impact factor: 4.784

3.  The pluripotency factor Nanog is directly upregulated by the androgen receptor in prostate cancer cells.

Authors:  Steven Kregel; Russell Z Szmulewitz; Donald J Vander Griend
Journal:  Prostate       Date:  2014-08-31       Impact factor: 4.104

Review 4.  Insights into the Nanog gene: A propeller for stemness in primitive stem cells.

Authors:  Wei Zhang; Yi Sui; Jun Ni; Tao Yang
Journal:  Int J Biol Sci       Date:  2016-10-25       Impact factor: 6.580

5.  Roles of NANOGP8 in cancer metastasis and cancer stem cell invasion during development of castration-resistant prostate cancer.

Authors:  Yi Sui; Wei Zhang; Rujian Zhu; Lili Gao; Ting Cao; Chuhong Chen; Min Gong; Hongbo Zhu; Tao Tang; Bo Yu; Tao Yang
Journal:  Ann Transl Med       Date:  2021-01

6.  Withaferin A Induces Cell Death Selectively in Androgen-Independent Prostate Cancer Cells but Not in Normal Fibroblast Cells.

Authors:  Yukihiro Nishikawa; Daisuke Okuzaki; Kohshiro Fukushima; Satomi Mukai; Shouichi Ohno; Yuki Ozaki; Norikazu Yabuta; Hiroshi Nojima
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

7.  Transgenic overexpression of NanogP8 in the mouse prostate is insufficient to initiate tumorigenesis but weakly promotes tumor development in the Hi-Myc mouse model.

Authors:  Bigang Liu; Shuai Gong; Qiuhui Li; Xin Chen; John Moore; Mahipal V Suraneni; Mark D Badeaux; Collene R Jeter; Jianjun Shen; Rashid Mehmood; Qingxia Fan; Dean G Tang
Journal:  Oncotarget       Date:  2017-04-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.